I see that the Australian Stroke Alliance's 3rd (late starter) imaging partner (Wellumio) has commenced its pivotal trial at Melbourne Hospital. Seems remarkably underfunded compared to EMV. Not sure how they have got this far with such small funding and so quickly.
https://aap.com.au/aapreleases/cision20250206ae12978/
I see that the Australian Stroke Alliance's 3rd (late starter)...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.020(1.14%) |
Mkt cap ! $148.7M | |||
| Open | High | Low | Value | Volume |
| $1.75 | $1.78 | $1.74 | $22.49K | 12.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 572 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 740 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |